Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Rabab Gaafar | Researchclopedia

Back to researchers

Rabab Gaafar

Cairo University ORCID

136

Works

3,848

Citations

29

h-index

50

i10-index

Research Topics

Occupational and environmental lung diseases Lung Cancer Treatments and Mutations Pleural and Pulmonary Diseases

Affiliations

Roche (Switzerland)2021–2021

European Organisation for Research and Treatment of Cancer2000–2010

Cairo University2000–2025

Heidelberg University2004–2007

Cancer Institute (WIA)2004–2018

Top Works

Randomized Phase III Study of Cisplatin With or Without Raltitrexed in Patients With Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

Jan P. van Meerbeeck,Rabab Gaafar,et al.

2005621 citations

Cancer Research and Treatments

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975

Egbert F. Smit,J.P.A.M van Meerbeeck,et al.

2003351 citations

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial

Paul Van Schil,Paul Baas,et al.

2010240 citations

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial

Lee M. Krug,Hedy L. Kindler,et al.

2015220 citations

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975

Fabio Efficace,Andrew Bottomley,et al.

2006182 citations

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

Giorgio V. Scagliotti,Rabab Gaafar,et al.

2019165 citations

Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer

Tanja Čufer,Eduard Vrdoljak,et al.

2006151 citations

Breast cancer in Egypt:a review of disease presentation and detection strategies

Sherif Omar,Hussein Khaled,et al.

2021149 citations

A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)

Rabab Gaafar,Veerle Surmont,et al.

2011119 citations